Committee for Orphan Medicinal Products (COMP): 10-12May 2017
Date:
10/05/2017 to 12/05/2017
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
COMP meeting report on the review of applications for orphan designation: May 2017 (PDF/122.61 KB)
First published: 24/05/2017
Last updated: 24/05/2017
EMA/COMP/265114/2017 -
List item
Minutes of the COMP meeting 10-12 May 2017 (PDF/347.58 KB)
Adopted
First published: 21/07/2017
Last updated: 21/07/2017
EMA/COMP/294665/2017